In this study deregulation of ASPP1 preferentially lead to development of lymphoid neoplasms, and attenuated levels of ASPP1 was confirmed in native ALL patient samples via methylation of the promoter region [10]. The gene discussed is PPP1R13B; the disease is lymphoid neoplasm.